Orphenadrine Extended-Release Tablets and Ribociclib Succinate
Determining the interaction of Orphenadrine Extended-Release Tablets and Ribociclib Succinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
Generic Name: ribociclib
Brand name: Kisqali
Synonyms: Ribociclib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Orphenadrine Extended-Release Tablets-Rid-A-Pain Topical
- Orphenadrine Extended-Release Tablets-Ridactate
- Orphenadrine Extended-Release Tablets-Ridaura
- Orphenadrine Extended-Release Tablets-Rifabutin
- Orphenadrine Extended-Release Tablets-Rifadin
- Orphenadrine Extended-Release Tablets-Rifadin IV
- Ribociclib Succinate-Orphenadrine Injection
- Ribociclib Succinate-Orphenadrine w/A.C.
- Ribociclib Succinate-Orphenadrine, aspirin, and caffeine
- Ribociclib Succinate-Orphenate
- Ribociclib Succinate-Orphengesic
- Ribociclib Succinate-Orphengesic Forte